Poly (ADP-Ribose) Polymerase Family, Member 9 (PARP9) Peptid
PARP9
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle PARP9 Produkte
- PARP9 (Poly (ADP-Ribose) Polymerase Family, Member 9 (PARP9))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- LHGGGLALAL VKAGGFEIQE ESKQFVARYG KVSAGEIAVT GAGRLPCKQI
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PARP9 antibody,
Alternative Names: PARP9 control peptide, PARP9 antibody Blocking Peptide, Anti-PARP9 Blocking Peptide, BAL Blocking Peptide, BAL1 Blocking Peptide, DKFZp666B0810 Blocking Peptide, DKFZp686M15238 Blocking Peptide, FLJ26637 Blocking Peptide, FLJ41418 Blocking Peptide, MGC:7868 Blocking Peptide, Adp-Ribose Polymerase 9 Blocking Peptide, Poly (ADP-ribose) polymerase 9 Blocking Peptide, PARP9, PARP-9, PARP 9, PARP-9 Blocking Peptide, PARP 9 Blocking Peptide - Aufreinigung
- Serum
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- PARP9 (Poly (ADP-Ribose) Polymerase Family, Member 9 (PARP9))
- Synonyme
- RGD1307534 Peptide, ARTD9 Peptide, BAL Peptide, BAL1 Peptide, MGC:7868 Peptide, AW214463 Peptide, BC003281 Peptide, Bagl Peptide, Bal Peptide, PARP-9 Peptide, poly (ADP-ribose) polymerase family, member 9 Peptide, poly(ADP-ribose) polymerase family member 9 Peptide, si:ch211-219a4.6 Peptide, Parp9 Peptide, PARP9 Peptide, si:ch211-219a4.6 Peptide
- Hintergrund
- PARP9 contains 2 Macro domains and 1 PARP catalytic domain. PARP9 is overexpressed at significantly higher levels in fatal high-risk diffuse large B-cell lymphomas (DLB-CL) compared to cured low-risk tumors. Overexpression of PARP9 in B-cell lymphoma transfectants may promote malignant B-cell migration. The function of PARP9 remains unknown.
- Molekulargewicht
- 96 kDa
-
Sie sind hier:
